Latest Articles

Publication Date
Endometrial cancer, Lorusso (Humanitas): "Immunotherapy is effective even in pMMR forms." - lamilano.it

Endometrial cancer, Lorusso (Humanitas): "Immunotherapy is effective even in pMMR forms." lamilano.it

Published: Feb. 23, 2026, 5:12 p.m.
DUO-E Phase III Trial: Durvalumab Plus Olaparib Maintenance in pMMR Endometrial Cancer - Oncodaily

DUO-E Phase III Trial: Durvalumab Plus Olaparib Maintenance in pMMR Endometrial Cancer Oncodaily

Published: Feb. 23, 2026, 6:45 a.m.
Giuseppe Caruso: Are all MMRd Endometrial Cancers Really the Same? - Oncodaily

Giuseppe Caruso: Are all MMRd Endometrial Cancers Really the Same? Oncodaily

Published: Feb. 22, 2026, 9:38 a.m.
Seen and heard: Hate aimed at Athika will only make women’s voices stronger - nation.cymru

Seen and heard: Hate aimed at Athika will only make women’s voices stronger nation.cymru

Published: Jan. 26, 2026, 8:17 p.m.
Penarth mum 'begged' for MRI which revealed cervical cancer - BBC

Penarth mum 'begged' for MRI which revealed cervical cancer BBC

Published: Jan. 25, 2026, 9:09 p.m.
After Fertility Loss, Care Barriers Remain For Women With Endometriosis, Says Local Woman - kfmradio.com

After Fertility Loss, Care Barriers Remain For Women With Endometriosis, Says Local Woman kfmradio.com

Published: Jan. 23, 2026, 2:37 p.m.
Targeted uterine mRNA treatment boosts fertility outcomes in mice - News-Medical

Targeted uterine mRNA treatment boosts fertility outcomes in mice News-Medical

Published: Jan. 23, 2026, 2:35 a.m.
Welsh health advocate targeted in abusive social media posts - nation.cymru

Welsh health advocate targeted in abusive social media posts nation.cymru

Published: Jan. 22, 2026, 7:01 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology

Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com

Published: Jan. 22, 2026, 4:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!